Medical News

RSS

ACP signs on to Code for Interactions with Companies released by CMSS

The American College of Physicians (ACP), the largest medical specialty organization and the second-largest physician group in the United States, has signed on to the CMSS Code for Interactions with Companies, released today by the Council of Medical Specialty Societies (CMSS). The intent of the code is to guide medical societies developing policies and procedures that safeguard the independence and transparency of their programs, policies, and advocacy positions in relationships with industry.

22 Apr 2010

Titan Pharmaceuticals expects approximately $1.6M as royalty on first-quarter sales of Fanapt

Titan Pharmaceuticals, Inc. today confirmed that the company expects to receive a payment of approximately $1.6 million by May 15, 2010 as the royalty on the first quarter 2010 sales of Fanapt™ (iloperidone), a drug for the treatment of schizophrenia launched in the US by Novartis Pharma AG in January 2010.

22 Apr 2010

Understanding genetic causes of mental retardation

This remarkable publication focuses on the importance of genetics in mental retardation, investigating the extent to which molecular diagnostic capability and the understanding of genetic causes have improved over recent years. As a result, clinical evaluation and diagnostic laboratory practice are now undergoing an unprecedented period of change.

22 Apr 2010

International Day for Fighting Infection focuses on hospital infection control

Hospital acquired infections are the focus for the 3rd International Day for Fighting Infection, being marked on St. George’s Day, as experts meet to look at the evolution of infection control in hospitals.

22 Apr 2010

New insight into mechanism regulating early mammalian development

Scientists at the Genome Institute of Singapore (GIS) have recently generated significant single cell expression data crucial for a detailed molecular understanding of mammalian development from fertilization to embryo implantation, a process known as the preimplantation period. The knowledge gained has a direct impact on clinical applications in the areas of regenerative medicine and assisted reproduction.

22 Apr 2010

Enigma ML instrument system to be showcased at InnovHealth 2010 summit

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it will be a product provider at the InnovHealth - Middle East Healthcare Innovations Summit in Abu Dhabi on 25 and 26 April 2010 and will be presenting the Enigma ("Mini Laboratory") instrument system.

22 Apr 2010

DiagnoCure's proprietary prostate cancer biomarker PCA3 presented at 2010 EAU meeting

DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that its proprietary prostate cancer biomarker PCA3 was the topic of over 13 presentations at the 2010 European Association of Urology meeting, the world largest urology event, held in Barcelona, Spain, with 14,000 registrants.

22 Apr 2010

ISHLT announces new guidelines for heart transplant recipients

The International Society for Heart and Lung Transplantation (ISHLT) today announces new guidelines to standardize care for heart transplant patients worldwide. The guidelines demonstrate a united effort to decrease complications, improve outcomes and increase patient survival rates among heart transplant recipients. The guidelines will be presented during today's symposium The ISHLT Guidelines for Heart Transplant Recipients: Towards an International Consensus at the ISHLT 30th Annual Meeting and Scientific Sessions at the Hilton Chicago.

22 Apr 2010

Canadian physicians have increased the use of clinical and pharmaceutical information: Study

New results from the Essential Physician Version 2.0 study indicate primary care physicians are changing the way they access and use clinical and pharmaceutical information. Physicians increasingly access online resources for relevant information they need on demand, even during and between patient visits.

22 Apr 2010

Syntagon contract research organisation announces strategic pricing initiative

Leading contract research organisation, Syntagon, has unveiled a strategic pricing initiative that will see substantial cost savings for biotechnology and pharmaceutical customers taking compounds into phase I and phase II clinical trials.

22 Apr 2010

Patient Protection and Affordability Act requirement goes into affect in September 2010: BCBSM

A diploma won't be the only thing carried away from high school and college commencement ceremonies in Michigan this spring. Young adults also will be carrying their parents' Blue Cross health insurance card.

22 Apr 2010

Gen-Probe's PROGENSA PCA3 assay helps determine necessity of initial biopsy in prostate cancer suspect men

Gen-Probe's PROGENSA® PCA3 assay can help predict the outcome of initial prostate biopsies in men suspected of having prostate cancer, according to a study of the molecular urine test presented in a scientific poster last week at the 25th annual European Association of Urology (EAU) Congress in Barcelona, Spain.

22 Apr 2010

ASTRO President speaks on radiation therapy for treatment of prostate cancer at MEDCAC meeting

ASTRO President Anthony Zietman, M.D., spoke before the Medicare Evidence Development and Coverage Advisory Committee meeting today on radiation therapy for treatment of localized prostate cancer. MEDCAC provides advice and recommendations to the Centers for Medicare and Medicaid Services for what is covered by Medicare and Medicaid, based on scientific evidence.

22 Apr 2010

Autonomy, Kainos release Evolve Electronic Document Management solution

Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, and Kainos, a leading IT consulting company, today announced the launch of Evolve™, a next-generation Electronic Document Management solution which enables instant and secure access to patient medical records through Autonomy's unique Meaning Based Computing solutions. The new system is already being trail blazed by Ipswich Hospital NHS Trust and is the successful outcome of months of collaboration between Kainos and Autonomy.

22 Apr 2010

GfK Kynetec announces acquisition of AIS

GfK Kynetec, the global leader in market research for the crop protection, biotechnology and animal health industries, announced today the acquisition of the non-crop business of Agricultural Information Services, London, UK. The acquisition enables GfK Kynetec to serve as the sole supplier of detailed data on the total global usage of crop protection products - within agriculture and in all other applications.

22 Apr 2010

World Bank report shows some MDG progress, country-level advancement 'uneven'

The world is on track to meet the poverty reduction target of the Millennium Development Goals, but sub-Saharan Africa still lags behind, according to the World Bank's World Development Indicators 2010 report, released Tuesday, VOA News reports (Hennessey, 4/20).

22 Apr 2010

Young adults to remain on parents' plan, states Aetna

Aetna today released the following statement regarding its decision to work with customers to extend dependent coverage to young adults.

22 Apr 2010

California's first Community Safety Saturday to be hosted in Carmel Plaza

The Protector Network and Capital Insurance Group Insurance Center's Central Valley Insurance Agency together with the California Highway Patrol and Visalia Police Department, host California's first Community Safety Saturday. This family friendly event will take place on Saturday, April 24, in the Carmel Plaza.

22 Apr 2010

AstraZeneca HealthCare Foundation's cardiovascular health program receives $25M charitable contribution

The AstraZeneca HealthCare Foundation announced today it received a $25 million charitable contribution from AstraZeneca for Connections for Cardiovascular Health(SM), its newest program with the mission of improving cardiovascular health in the United States.

22 Apr 2010

Cybex International defends intellectual property rights related to patented Plate Loaded Leg Press

Cybex International, Inc., a leading manufacturer of premium exercise equipment, announced today that it has decisively responded to infringements of its intellectual property rights related to its patented Plate Loaded Leg Press and the company's pending patent applications for the Bravo Functional Trainer.

22 Apr 2010

Medical News

ACP signs on to Code for Interactions with Companies released by CMSS

Titan Pharmaceuticals expects approximately $1.6M as royalty on first-quarter sales of Fanapt

Understanding genetic causes of mental retardation

International Day for Fighting Infection focuses on hospital infection control

New insight into mechanism regulating early mammalian development

Enigma ML instrument system to be showcased at InnovHealth 2010 summit

DiagnoCure's proprietary prostate cancer biomarker PCA3 presented at 2010 EAU meeting

ISHLT announces new guidelines for heart transplant recipients

Canadian physicians have increased the use of clinical and pharmaceutical information: Study

Syntagon contract research organisation announces strategic pricing initiative

Patient Protection and Affordability Act requirement goes into affect in September 2010: BCBSM

Gen-Probe's PROGENSA PCA3 assay helps determine necessity of initial biopsy in prostate cancer suspect men

ASTRO President speaks on radiation therapy for treatment of prostate cancer at MEDCAC meeting

Autonomy, Kainos release Evolve Electronic Document Management solution

GfK Kynetec announces acquisition of AIS

World Bank report shows some MDG progress, country-level advancement 'uneven'

Young adults to remain on parents' plan, states Aetna

California's first Community Safety Saturday to be hosted in Carmel Plaza

AstraZeneca HealthCare Foundation's cardiovascular health program receives $25M charitable contribution

Cybex International defends intellectual property rights related to patented Plate Loaded Leg Press

The importance of ketones from a clinical and medical perspective

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Latest News